199,683 Shares in Pediatrix Medical Group, Inc. $MD Acquired by Edgestream Partners L.P.

Edgestream Partners L.P. purchased a new position in Pediatrix Medical Group, Inc. (NYSE:MD – Free Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 199,683 shares of the company’s stock, valued at approximately $5,138,000. Edgestream Partners L.P. owned 0.26% of Pediatrix Medical Group at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. BlackRock Inc. bought a new position in shares of Pediatrix Medical Group in the second quarter valued at approximately $347,383,000. Bank of New York Mellon Corp bought a new position in Pediatrix Medical Group in the 2nd quarter valued at $14,297,000. Empowered Funds LLC bought a new position in shares of Pediatrix Medical Group in the second quarter worth $12,668,000. Allspring Global Investments Holdings LLC raised its position in shares of Pediatrix Medical Group by 27.9% in the third quarter. Allspring Global Investments Holdings LLC now owns 2,070,961 shares of the company’s stock worth $53,348,000 after buying an additional 452,051 shares in the last quarter. Finally, Wasatch Advisors LP raised its position in shares of Pediatrix Medical Group by 21.9% in the second quarter. Wasatch Advisors LP now owns 2,498,884 shares of the company’s stock worth $63,297,000 after buying an additional 448,360 shares in the last quarter. 97.71% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of brokerages have weighed in on MD. UBS Group upped their target price on Pediatrix Medical Group from $25.00 to $28.00 and gave the stock a “neutral” rating in a research note on Thursday, August 6th. Jefferies Financial Group lowered shares of Pediatrix Medical Group from a “buy” rating to a “hold” rating and lifted their target price for the company from $27.00 to $28.00 in a research report on Wednesday, August 19th. Deutsche Bank reissued a “hold” rating and issued a $25.00 price target on shares of Pediatrix Medical Group in a report on Wednesday, August 5th. Weiss Ratings upgraded shares of Pediatrix Medical Group from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, September 9th. Finally, Mizuho lowered Pediatrix Medical Group from a “neutral” rating to an “underperform” rating and set a $28.00 price objective on the stock. in a research report on Wednesday, November 11th. One analyst has rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Pediatrix Medical Group currently has a consensus rating of “Hold” and a consensus price target of $28.00.

View Our Latest Analysis on Pediatrix Medical Group

Pediatrix Medical Group Price Performance

Shares of Pediatrix Medical Group stock opened at $30.84 on Thursday. Pediatrix Medical Group, Inc. has a 12-month low of $17.23 and a 12-month high of $33.74. The firm has a market cap of $2.41 billion, a PE ratio of 16.76 and a beta of 0.62. The company has a quick ratio of 1.28, a current ratio of 1.28 and a debt-to-equity ratio of 0.47. The company’s fifty day simple moving average is $28.14 and its two-hundred day simple moving average is $24.50.

Pediatrix Medical Group (NYSE:MD – Get Free Report) last released its quarterly earnings results on Thursday, October 29th. The company reported $0.72 EPS for the quarter, beating analysts’ consensus estimates of $0.65 by $0.07. The business had revenue of $501.37 million during the quarter, compared to analyst estimates of $498.18 million. Pediatrix Medical Group had a return on equity of 20.12% and a net margin of 7.66%. Pediatrix Medical Group’s quarterly revenue was up 1.7% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.67 EPS. As a group, equities analysts expect that Pediatrix Medical Group, Inc. will post 2.22 EPS for the current year.

About Pediatrix Medical Group

(Free Report)

Pediatrix Medical Group provides physician services to hospitals and other healthcare facilities across the United States. Its clinicians care for women, newborns and children, working with healthcare partners to support patients in hospital and other clinical settings. The company’s services include neonatal care, maternal-fetal medicine and pediatric subspecialties. Its physicians and advanced practice providers deliver care such as treatment for high-risk pregnancies and specialized medical services for newborns and children.

See Also

Want to see what other hedge funds are holding MD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pediatrix Medical Group, Inc. (NYSE:MD – Free Report).

Institutional Ownership by Quarter for Pediatrix Medical Group (NYSE:MD)

Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.